These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10889554)
1. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Eastwood SL; Harrison PJ Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554 [TBL] [Abstract][Full Text] [Related]
2. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Harrison PJ; Eastwood SL Lancet; 1998 Nov; 352(9141):1669-73. PubMed ID: 9853440 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Eastwood SL; Harrison PJ Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259 [TBL] [Abstract][Full Text] [Related]
4. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Law AJ; Weickert CS; Hyde TM; Kleinman JE; Harrison PJ Am J Psychiatry; 2004 Oct; 161(10):1848-55. PubMed ID: 15465982 [TBL] [Abstract][Full Text] [Related]
5. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Eastwood SL; Burnet PW; Harrison PJ Synapse; 2000 Jun; 36(3):167-77. PubMed ID: 10819897 [TBL] [Abstract][Full Text] [Related]
6. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Eastwood SL; Harrison PJ Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753 [TBL] [Abstract][Full Text] [Related]
7. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239 [TBL] [Abstract][Full Text] [Related]
8. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Uezato A; Meador-Woodruff JH; McCullumsmith RE Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996 [TBL] [Abstract][Full Text] [Related]
9. Cerebellar synaptic protein expression in schizophrenia. Eastwood SL; Cotter D; Harrison PJ Neuroscience; 2001; 105(1):219-29. PubMed ID: 11483314 [TBL] [Abstract][Full Text] [Related]
10. Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Eastwood SL; Harrison PJ Neuropsychopharmacology; 2008 Mar; 33(4):933-45. PubMed ID: 17507910 [TBL] [Abstract][Full Text] [Related]
11. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Eastwood SL; Burnet PW; Harrison PJ Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874 [TBL] [Abstract][Full Text] [Related]
12. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Sawada K; Young CE; Barr AM; Longworth K; Takahashi S; Arango V; Mann JJ; Dwork AJ; Falkai P; Phillips AG; Honer WG Mol Psychiatry; 2002; 7(5):484-92. PubMed ID: 12082566 [TBL] [Abstract][Full Text] [Related]
13. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Föcking M; Dicker P; English JA; Schubert KO; Dunn MJ; Cotter DR Arch Gen Psychiatry; 2011 May; 68(5):477-88. PubMed ID: 21536977 [TBL] [Abstract][Full Text] [Related]
14. Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder. Konopaske GT; Subburaju S; Coyle JT; Benes FM Schizophr Res; 2015 May; 164(1-3):100-8. PubMed ID: 25757715 [TBL] [Abstract][Full Text] [Related]
15. In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder. Haukvik UK; Westlye LT; Mørch-Johnsen L; Jørgensen KN; Lange EH; Dale AM; Melle I; Andreassen OA; Agartz I Biol Psychiatry; 2015 Mar; 77(6):581-8. PubMed ID: 25127742 [TBL] [Abstract][Full Text] [Related]
16. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Fatemi SH; Earle JA; McMenomy T Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396 [TBL] [Abstract][Full Text] [Related]
17. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Gaughran F; Payne J; Sedgwick PM; Cotter D; Berry M Brain Res Bull; 2006 Jul; 70(3):221-7. PubMed ID: 16861106 [TBL] [Abstract][Full Text] [Related]
18. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Thompson Ray M; Weickert CS; Wyatt E; Webster MJ J Psychiatry Neurosci; 2011 May; 36(3):195-203. PubMed ID: 21223646 [TBL] [Abstract][Full Text] [Related]
19. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Heckers S; Stone D; Walsh J; Shick J; Koul P; Benes FM Arch Gen Psychiatry; 2002 Jun; 59(6):521-9. PubMed ID: 12044194 [TBL] [Abstract][Full Text] [Related]
20. Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. Aas M; Haukvik UK; Djurovic S; Tesli M; Athanasiu L; Bjella T; Hansson L; Cattaneo A; Agartz I; Andreassen OA; Melle I J Psychiatr Res; 2014 Dec; 59():14-21. PubMed ID: 25246365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]